DQWS.US DSwiss Inc
- Market cap
- USD 17.4M
- P/E
- -
- P/B
- 25.65x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is DQWS.US undervalued?
Graham numberThe Graham number of DSwiss Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
DSwiss Inc fundamental analysis
No fundamental analysis for DSwiss Inc yet.
DSwiss Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About DSwiss Inc
DSwiss, Inc., a biotech nutraceutical company, provides healthcare, skincare, and personal care products in Malaysia, Singapore, Indonesia, Australia, Hong Kong, Taiwan, Macau, and China. It supplies health and beauty products, including weight management beverages, anti-aging creams, and immune system enhancers. The company also provides private label manufacturing services for nutraceutical and skincare/personal care ODM/OEM products; pet wellness supplements; and pet-care…
Full company profileDSwiss Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
DSwiss Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 137K | 181K | 220K | 274K | 1.35M | 1.96M | 1.85M | 1.47M | 3.11M | 2.92M | 1.98M |
| Gross Profit | 72.2K | 145K | 41.8K | 91.7K | 367K | 499K | 445K | 359K | 623K | 565K | 657K |
| Operating Income | -323K | -59.2K | -379K | -286K | 138K | 153K | 3.79K | -52.9K | 19.6K | -85.5K | 10.4K |
| EBITDA | -496K | -259K | -347K | -227K | 202K | 219K | 77.3K | 20.0K | 50.2K | 18.3K | 93.8K |
| Net Income | -508K | -284K | -351K | -352K | 27.2K | 173K | -14.3K | -49.5K | 22.2K | -76.9K | 3.58K |
| EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Balance Sheet | |||||||||||
| Total Assets | 922K | 673K | 379K | 366K | 344K | 498K | 382K | 367K | 636K | 677K | 637K |
| Total Liabilities | 720K | 86.2K | 178K | 470K | 414K | 424K | 284K | 311K | 562K | 686K | 645K |
| Shareholders' Equity | 170K | 555K | 190K | -109K | -95.2K | 73.4K | 86.3K | 56.4K | 74.0K | -9.35K | -7.82K |
| Cash & Short-term Investments | 783K | 499K | 189K | 48.4K | 158K | 235K | 214K | 249K | 397K | 285K | 258K |
| Total Debt | 656K | 15.7K | 56.3K | 142K | 90.3K | 167K | 99.5K | 37.0K | 106K | 282K | 250K |
| Cash Flow | |||||||||||
| Operating Cash Flow | -550K | -346K | -250K | -180K | 58.9K | 252K | 22.4K | 45.3K | 183K | -94.3K | -10.6K |
| Capital Expenditure | 62.6K | 1.99K | 84.0K | 2.08K | 2.05K | 62.1K | 14.4K | 373.00 | 106K | 41.0K | 608.00 |
| Free Cash Flow | -613K | -348K | -334K | -182K | 56.9K | 190K | 8.05K | 44.9K | 77.0K | -135K | -10.3K |
| Ratios | |||||||||||
| ROE | -298.8% | -51.2% | -185.2% | - | - | 236.3% | -16.6% | -87.8% | 30.0% | - | - |
| ROA | -55.1% | -42.2% | -92.6% | -96.2% | 7.9% | 34.8% | -3.7% | -13.5% | 3.5% | -11.4% | 0.6% |
| Net Profit Margin | -370.4% | -156.8% | -159.6% | -128.6% | 2.0% | 8.9% | -0.8% | -3.4% | 0.7% | -2.6% | 0.2% |
| Debt to Equity | 3.86x | 0.03x | 0.30x | - | - | 2.28x | 1.15x | 0.66x | 1.44x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
DSwiss Inc dividends
DSwiss Inc has not paid dividends in the last 9 fiscal years.
Who owns DSwiss Inc
- Insiders 90.86%
- Institutions 0.00%
- Public & others 9.14%
- Shares outstanding 207M
- Free float 18.9M
DSwiss Inc company profile
- Company name
- DSwiss Inc
- Ticker
- DQWS.US
- Exchange
- USA Stocks
- Sector
- Consumer Defensive
- Industry
- Personal Care Products
- Employees
- 30
- Fiscal year end
- December
- Address
- B-10-08, Tower B, Kuala Lumpur, Malaysia, 59200
- Phone
- 60 3 2242 4032
- Website
- dswissbeauty.com
About DSwiss Inc
DSwiss, Inc., a biotech nutraceutical company, provides healthcare, skincare, and personal care products in Malaysia, Singapore, Indonesia, Australia, Hong Kong, Taiwan, Macau, and China. It supplies health and beauty products, including weight management beverages, anti-aging creams, and immune system enhancers. The company also provides private label manufacturing services for nutraceutical and skincare/personal care ODM/OEM products; pet wellness supplements; and pet-care products, as well as medical consumable supplies, such as disposable stretcher cover and bedsheet, masks, body infrared thermometers, sanitizer, protective goggles, surgical gloves, isolation suit, industrial disinfectant, and protection surgical and medical gown. In addition, it offers OEM/ODM/OBM services, such as DSwiss quantum magnetic analyzer and DNA genotyping services; Eyecare; and biotechnology research channel services. DSwiss, Inc. was incorporated in 2015 and is headquartered in Kuala Lumpur, Malaysia.
DSwiss Inc management
1- Mr. Ming Chia LeongFounder, CEO, President, CFO, Secretary, Treasurer & Director · born 1982